<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pigmentary mosaicism (hypomelanosis of Ito)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pigmentary mosaicism (hypomelanosis of Ito)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pigmentary mosaicism (hypomelanosis of Ito)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Julie V Schaffer, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Karen A Chernoff, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer L Hand, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 27, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1995378754"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The term "pigmentary mosaicism" refers to patterned hypo- or hyperpigmentation resulting from a clone of skin cells with altered ability to produce melanin [<a href="#rid1">1</a>]. The three major clinical patterns are streaks and swirls following the Blaschko lines  (<a class="graphic graphic_figure graphicRef57219" href="/z/d/graphic/57219.html" rel="external">figure 1</a>), a segmental or "checkerboard" distribution, and a phylloid (leaf-like) arrangement.</p><p>This topic will discuss the epidemiology, pathogenesis, clinical manifestations, diagnosis, and treatment of pigmentary mosaicism. Other inherited and acquired disorders of pigmentation are discussed separately. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15513.html" rel="external">"Incontinentia pigmenti"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/89268.html" rel="external">"Acquired hyperpigmentation disorders"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/103736.html" rel="external">"Acquired hypopigmentation disorders other than vitiligo"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/105109.html" rel="external">"Vitiligo: Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H3947322915"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>A variety of terms have been used for different clinical presentations within the spectrum of pigmentary mosaicism. "Hypomelanosis of Ito" (HOI) and "linear and whorled nevoid hypermelanosis" (LWNH) generally refer to hypo- and hyperpigmentation along the Blaschko lines, respectively. Extracutaneous manifestations occur in a minority of individuals with these skin findings [<a href="#rid2">2,3</a>]. However, HOI series from pediatric neurology centers describe high frequencies of neurologic abnormalities, which reflect an obvious referral bias, and some authors limit the diagnosis of HOI to patients with extracutaneous abnormalities [<a href="#rid4">4,5</a>]. </p><p>To avoid unnecessary concern based upon these uses of the HOI appellation and to acknowledge the similar nature of LWNH, alternative descriptive names, such as "linear nevoid hypo-/hyperpigmentation" (used herein) and "Blaschkoid dyspigmentation," have been proposed [<a href="#rid2">2,3</a>]. Of note, the term "incontinentia pigmenti achromians" that was originally coined by Ito for linear nevoid hypopigmentation is no longer used to avoid confusion with incontinentia pigmenti, a completely separate condition.</p><p>Multiple terms have also been utilized for pigmentary mosaicism in a checkerboard pattern, including "segmental nevus depigmentosus," "segmental pigmentation disorder" (used herein), and "flag-like hypo- or hypermelanotic nevus" [<a href="#rid6">6-9</a>]. Cutis tricolor refers to patterned hypo- and hyperpigmentation in a background of skin with an intermediate level of pigmentation.</p><p class="headingAnchor" id="H1821151924"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The exact prevalence of pigmentary mosaicism is unknown. Studies in Hispanic children have found that hypomelanosis of Ito (HOI), defined as extensive linear or patchy hypopigmentation (affecting ≥3 body regions) with associated extracutaneous findings, was present in approximately 1 of 8000 general pediatric outpatients and 1 of 800 pediatric dermatology outpatients [<a href="#rid4">4,10</a>]. Pigmentary mosaicism without associated extracutaneous findings may not come to medical attention, especially when relatively subtle or not extensive, and is likely underreported in the literature. Segmental pigmentation disorder is thought to be relatively common, with one study estimating its presence in approximately 1 of 250 Israeli pediatric dermatology outpatients [<a href="#rid7">7,8</a>].</p><p>Pigmentary mosaicism has no clear sex predilection and is almost always sporadic, with rare reports of possible familial occurrence [<a href="#rid11">11-13</a>]. Although it can affect individuals of any ethnic background, pigmentary mosaicism is often more apparent in those with darkly pigmented or tanned skin. The areas of patterned hypo- or hyperpigmentation may be noticed at birth or become evident during the first few years of life. Delayed presentation is common in fair-skinned individuals, and hypopigmentation may go unnoticed until the contrast with the surrounding skin is accentuated following sun exposure.</p><p class="headingAnchor" id="H3000146059"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Mosaicism refers to an organism composed of at least two genetically different cell populations that originate from a homogeneous zygote. Pigmentary mosaicism results from a postzygotic mutation or other genetic change that alters the pigment production potential of daughter cells destined to be located in the skin. If daughter cells also migrate to other organs (eg, central nervous system, musculoskeletal system) and the genetic change has local detrimental effects, extracutaneous manifestations may occur. The extent of involvement of the skin (and potentially of other organs) is thought to be greater when the causal genetic event occurred earlier during the embryogenesis.</p><p>Multiple types of mosaic cytogenetic abnormalities have been found to underlie linear nevoid hypo-/hyperpigmentation, including numerical (eg, trisomy 18 or 20, triploidy) and structural (eg, deletions, duplications, translocations) chromosomal aberrations. Alterations in nearly every chromosome have been reported to cause pigmentary mosaicism. However, approximately 90 percent of the cytogenetic abnormalities involve loci of genes known to be involved in skin pigmentation, with more than 50 different pigmentary genes shown to be implicated in at least one patient [<a href="#rid5">5</a>]. Smaller-scale mutations (eg, point mutations) in a specific gene have less often been implicated. For example, asymmetric megalencephaly with polymicrogyria associated with nevoid hypo- and hyperpigmentation has been associated with a mosaic point mutation in the mechanistic target of rapamycin (mTOR) gene [<a href="#rid14">14</a>].</p><p>The types of genetic changes that cause segmental pigmentation disorder remain to be determined. By contrast, phylloid hypomelanosis is a distinct clinicogenetic entity caused by mosaic trisomy (or occasionally tetrasomy) 13q [<a href="#rid15">15</a>]. There are also rare reports of phylloid hypermelanosis, which has been linked to several different chromosomal aberrations [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H52815050"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Patients with pigmentary mosaicism present with hypo- or hyperpigmentation along Blaschko lines or in a checkerboard pattern. The use of a Wood's lamp may help to better delineate the affected areas when the hypo- or hyperpigmentation is subtle. Some patients have a combination of linear and segmental hypo- and/or hyperpigmentation. (See  <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">"Office-based dermatologic diagnostic procedures", section on 'Wood's lamp examination (black light)'</a>.)</p><p class="headingAnchor" id="H959610377"><span class="h2">Linear nevoid hypo-/hyperpigmentation</span><span class="headingEndMark"> — </span>In patients with linear nevoid hypo-/hyperpigmentation, streaks and swirls of hypo- or hyperpigmentation following Blaschko lines can occur anywhere on the body, forming V-shapes on the central back; S-shapes on the anterior trunk; and long, narrow bands on the extremities  (<a class="graphic graphic_picture graphicRef110210 graphicRef110211" href="/z/d/graphic/110210.html" rel="external">picture 1A-B</a>). Involvement may be unilateral or bilateral, localized or widespread [<a href="#rid4">4</a>]. When extensive, it is sometimes difficult to determine whether the lighter or darker skin represents the background color  (<a class="graphic graphic_picture graphicRef110212" href="/z/d/graphic/110212.html" rel="external">picture 2</a>). Occasionally, both hypo- and hyperpigmented streaks are present in different areas [<a href="#rid3">3,17</a>]. Scalp involvement can lead to spiral bands of lighter or darker hair [<a href="#rid18">18</a>]. There have been a few reports of associated hypohidrosis or separate streaks of Blaschko-linear hypertrichosis [<a href="#rid4">4,9,19,20</a>].</p><p class="headingAnchor" id="H3092955026"><span class="h3">Extracutaneous manifestations</span><span class="headingEndMark"> — </span>Extracutaneous involvement in patients with linear nevoid hypo-/hyperpigmentation most commonly affects the central nervous system and musculoskeletal system. The exact prevalence is unknown. Older series from pediatric neurology centers reported central nervous system abnormalities in over 80 percent of patients, but these findings are not generalizable due to a strong referral bias [<a href="#rid4">4,10</a>]. Series from pediatric dermatology referral centers have documented a 15 to 30 percent prevalence of extracutaneous findings in these patients [<a href="#rid2">2,3</a>]. Considering that healthy children without extensive skin involvement would be less likely to see a subspecialized pediatric dermatologist, the frequency is probably even lower. Of note, many experts recommend reserving the term "hypomelanosis of Ito" for patients with linear nevoid hypo-/hyperpigmentation associated with extracutaneous manifestations [<a href="#rid4">4,5,21</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Signs and symptoms of central nervous system involvement usually arise during infancy, but milder manifestations occasionally have a later onset. Developmental delay and seizures are the most frequent clinical findings [<a href="#rid2">2,3,22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Associated musculoskeletal anomalies include hemihyperplasia or hemihypoplasia, scoliosis, coarse facies, and abnormal digits [<a href="#rid4">4,23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ocular abnormalities and congenital heart disease have been reported in a small minority of affected individuals, with variable manifestations that reflect the diversity of the underlying genetic defects [<a href="#rid4">4,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pallister-Killian syndrome due to mosaic tetrasomy 12p features linear nevoid hypo-/hyperpigmentation together with craniofacial dysmorphism, congenital heart defects, congenital diaphragmatic hernia, hypotonia, seizures, and intellectual disability [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/452.html" rel="external">"Congenital cytogenetic abnormalities", section on '47,+i(12p)'</a>.)</p><p></p><p class="headingAnchor" id="H3732874614"><span class="h2">Segmental pigmentation disorder</span><span class="headingEndMark"> — </span>In patients with segmental pigmentation disorder, hypo- or hyperpigmented patches have a segmental pattern that has been referred to as block-like, flag-like, or resembling a checkerboard  (<a class="graphic graphic_picture graphicRef110214" href="/z/d/graphic/110214.html" rel="external">picture 3</a>). Any site can be affected, but the trunk is favored. Midline demarcation is more often present ventrally (approximately 80 percent of cases) than dorsally. Lesions tend to be less well-defined laterally and occasionally extend past the midline by a few centimeters [<a href="#rid7">7,8</a>]. The shape is frequently quadrangular, and the margins may be serrated [<a href="#rid9">9</a>].</p><p>Segmental pigmentation disorder is not usually associated with extracutaneous abnormalities. Affected areas occasionally develop multiple superimposed lentigines or melanocytic nevi, including Spitz nevi. If the background patch is hyperpigmented, this leads to a diagnosis of speckled lentiginous nevus (nevus spilus). (See <a class="local">'Differential diagnosis'</a> below.)</p><p>Segmental hyperpigmentation sometimes coexists with a light red-pink capillary malformation; this association is referred to as "phacomatosis melanorosea" [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/5789.html" rel="external">"Vascular lesions in the newborn", section on 'Phakomatosis pigmentovascularis'</a>.)</p><p class="headingAnchor" id="H202219482"><span class="h2">Phylloid hypomelanosis and hypermelanosis</span><span class="headingEndMark"> — </span>The phylloid pattern is composed of leaf-like, pear-shaped, and oblong lesions in an arrangement reminiscent of a floral ornament  (<a class="graphic graphic_picture graphicRef110216" href="/z/d/graphic/110216.html" rel="external">picture 4</a>). </p><p>Phylloid hypomelanosis is a distinct clinicogenetic entity associated with mosaic abnormalities of chromosome 13 (trisomy and tetrasomy 13q). It presents with additional cutaneous and extracutaneous features, including telangiectatic macules, thick eyebrows, long eyelashes, low frontal hairline, seizures, intellectual disability, agenesis of the corpus callosum, conductive hearing loss, colobomas, and skeletal defects that often involve the digits [<a href="#rid15">15,25</a>]. </p><p>Only a few cases of phylloid hypermelanosis have been reported, with variable extracutaneous manifestations [<a href="#rid16">16,26</a>]. Mosaic abnormalities of chromosome 13 have been documented in some but not all cases of phylloid hypermelanosis [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H1967156656"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>Hypopigmented lesions have a normal or reduced number of melanocytes [<a href="#rid28">28,29</a>]. Hyperpigmented lesions typically show increased pigmentation in the basal layer of the epidermis and a normal or slightly increased number of melanocytes [<a href="#rid30">30-32</a>].</p><p class="headingAnchor" id="H4275266855"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of the various types of pigmentary mosaicism is made clinically. Although the histopathologic findings are nonspecific, a skin biopsy is occasionally helpful in excluding alternative diagnoses when the clinical findings are atypical. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H435880959"><span class="h2">History and physical examination</span><span class="headingEndMark"> — </span>A thorough history and physical examination should be performed to assess for extracutaneous involvement, with further evaluation directed by any abnormal findings. Neurodevelopmental progress should be followed by the child's pediatrician, with additional intervention if needed.</p><p class="headingAnchor" id="H843823826"><span class="h2">Genetic analysis</span><span class="headingEndMark"> — </span>Identification of the underlying genetic alteration does not usually affect the management of patients with pigmentary mosaicism. However, genetic analysis should be considered in children with extracutaneous abnormalities, as it may provide a more accurate diagnosis. </p><p>Karyotyping of peripheral blood lymphocytes reveals mosaic chromosomal abnormalities in up to one-third of patients with linear nevoid hypopigmentation. In an additional one-fourth of affected individuals, chromosomal abnormalities can be detected by genetic analysis of lesional skin fibroblasts [<a href="#rid33">33</a>]. </p><p>Because Blaschko lines reflect pathways of ectodermal<em> </em>cell migration during embryonic development, the mosaic abnormality may be confined to epidermal cells. Although analysis of lesional keratinocytes or melanocytes rather than fibroblasts would likely be of higher yield, keratinocyte and melanocyte cultures are not routinely performed at most cytogenetic laboratories [<a href="#rid34">34</a>]. </p><p>More sensitive techniques such as array comparative genomic hybridization (aCGH) may also be useful in identifying submicroscopic genetic abnormalities (eg, microdeletions, microduplications) that are not detected with conventional cytogenetic methods. Analysis of specific genes or whole exome/genome sequencing utilizing lesional samples may be helpful in patients with extracutaneous manifestations suggestive of a particular diagnosis or type of disorder [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H760887260"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Several conditions can present with hypo- or hyperpigmentation along Blaschko lines or in a checkerboard pattern. The clinical and histopathologic clues highlighted below may help determining the correct diagnosis.</p><p class="headingAnchor" id="H184334687"><span class="h2">Hypopigmentation along Blaschko lines</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lichen striatus</strong> – Lichen striatus is a benign, self-limited, inflammatory dermatitis that most often develops in children. It typically has a sudden onset and favors the extremities. In individuals with darker or tanned skin, lichen striatus can present as hypopigmented streaks composed of macules and barely elevated papules  (<a class="graphic graphic_picture graphicRef94731" href="/z/d/graphic/94731.html" rel="external">picture 5</a>). If the diagnosis is uncertain, a skin biopsy showing a lymphocytic infiltrate centered on eccrine glands and hair follicles can clarify the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/13731.html" rel="external">"Lichen striatus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidermal nevus </strong>– Epidermal nevus is a benign, hamartomatous growth of the skin. Lesions usually become apparent during the first year of life and are occasionally hypopigmented, especially in children with darker skin  (<a class="graphic graphic_picture graphicRef110235" href="/z/d/graphic/110235.html" rel="external">picture 6</a>). Subtle elevation and textural changes that are most evident in flexural and acral sites suggest the diagnosis. Histology shows hyperkeratosis, acanthosis, and papillomatosis. (See  <a class="medical medical_review" href="/z/d/html/13728.html" rel="external">"Epidermal nevus and epidermal nevus syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nevus comedonicus</strong> – Nevus comedonicus may present at birth or later in childhood as grouped comedones superimposed on hypopigmented streaks. The clinical diagnosis is usually straightforward.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Linear lichen sclerosus</strong> – Extragenital lichen sclerosus is a chronic inflammatory disorder typically presenting with porcelain white, atrophic plaques on the skin. Hypopigmented bands with a shiny, wrinkled surface and follicular plugging can develop at any age. Biopsy shows characteristic homogenization of the upper dermis with epidermal thinning and a variable lymphocytic infiltrate. (See  <a class="medical medical_review" href="/z/d/html/15838.html" rel="external">"Extragenital lichen sclerosus: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Focal dermal hypoplasia (Goltz syndrome)</strong> – Focal dermal hypoplasia is a rare multisystem connective tissue genodermatosis characterized by streaks of hypopigmentation typically accompanied by congenital cribriform dermal atrophy and fat "herniation"  (<a class="graphic graphic_picture graphicRef110238" href="/z/d/graphic/110238.html" rel="external">picture 7</a>). Additional findings in this X-linked dominant condition include raspberry-like papillomas, ectrodactyly, other bony defects, and anomalies of the eyes, nails, hair, and teeth. (See  <a class="medical medical_review" href="/z/d/html/117132.html" rel="external">"Focal dermal hypoplasia (Goltz syndrome)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incontinentia pigmenti, stage 4</strong> – Incontinentia pigmenti is an X-linked dominant genodermatosis presenting in females as a staged, linear cutaneous eruption. Stage 4 is characterized by hypopigmented, hairless, and atrophic streaks resembling "Chinese characters." It often has onset in the teens and favors the calves, with variable preceding vesicular, verrucous, and/or hyperpigmented stages. This X-linked dominant disorder may also affect the teeth, hair, nails, and eyes. (See  <a class="medical medical_review" href="/z/d/html/15513.html" rel="external">"Incontinentia pigmenti"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Menkes syndrome, female carrier</strong> – Menkes syndrome is an X-linked recessive disease of copper metabolism characterized by neurologic, connective tissue, skin, hair, bone, bladder, and arterial abnormalities [<a href="#rid35">35</a>]. Hypopigmented streaks and pili torti of scalp hair may be present in carriers of this X-linked condition. (See  <a class="medical medical_review" href="/z/d/html/2585.html" rel="external">"Overview of dietary trace elements", section on 'Menkes disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Linear Darier disease</strong> – Darier disease is a rare genodermatosis characterized by a persistent eruption of greasy hyperkeratotic papules in seborrheic regions. In the linear variant, affected streaks may contain guttate hypopigmented macules and/or keratotic papules. A skin biopsy showing acantholytic dyskeratosis is diagnostic. (See  <a class="medical medical_review" href="/z/d/html/15462.html" rel="external">"Darier disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Conradi-Hünermann-Happle syndrome </strong>–<strong> </strong>Congenital X-linked dominant chondrodysplasia punctata type 2 (Conradi-Hünermann-Happle syndrome) presents at birth as a congenital ichthyosiform erythroderma that clears over months and is replaced by linear hyperkeratosis, follicular atrophoderma, and pigmentary abnormalities. Follicular atrophoderma is typically present in the hypopigmented streaks, and there is usually a history of neonatal ichthyosiform erythroderma with feathery scale following the Blaschko lines  (<a class="graphic graphic_picture graphicRef110242" href="/z/d/graphic/110242.html" rel="external">picture 8</a>). Other features of this X-linked dominant disorder include patchy scarring alopecia, unilateral cataracts, and asymmetric skeletal anomalies. (See  <a class="medical medical_review" href="/z/d/html/15465.html" rel="external">"Overview and classification of the inherited ichthyoses", section on 'X-linked dominant disorders'</a>.)</p><p></p><p class="headingAnchor" id="H409742531"><span class="h2">Hyperpigmentation along Blaschko lines</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidermal nevus</strong> – Early or minimally elevated lesions can be mistaken for pigmentary mosaicism. Subtle textural changes tend to be most evident in flexural and acral sites  (<a class="graphic graphic_picture graphicRef89782" href="/z/d/graphic/89782.html" rel="external">picture 9</a>). When performed, biopsy shows hyperkeratosis, acanthosis, and papillomatosis. (See  <a class="medical medical_review" href="/z/d/html/13728.html" rel="external">"Epidermal nevus and epidermal nevus syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incontinentia pigmenti, stage 3</strong> – Streaks of reticulate gray-brown hyperpigmentation with characteristic scalloped borders favor the trunk and intertriginous sites  (<a class="graphic graphic_picture graphicRef89807" href="/z/d/graphic/89807.html" rel="external">picture 10</a>). Stage 3 typically occurs from infancy through early adolescence, often but not always preceded by vesicular and verrucous stages. This X-linked dominant disorder may also affect the teeth, hair, nails, and eyes. Biopsy shows prominent dermal melanophages. (See  <a class="medical medical_review" href="/z/d/html/15513.html" rel="external">"Incontinentia pigmenti"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>X-linked hypohidrotic ectodermal dysplasia (female patients) </strong>– Hyperpigmented swirls (most evident on the back) are smooth and lack adnexa. They tend to be more obvious and have earlier onset in patients with darker skin. This X-linked condition also features peg-shaped or missing teeth and decreased hair density [<a href="#rid36">36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Linear atrophoderma of Moulin </strong>– Atrophoderma of Moulin is a rare disorder characterized by unilateral bands of hyperpigmented and atrophic plaques that follow the lines of Blaschko [<a href="#rid37">37</a>]. Hyperpigmented streaks are slightly depressed with "cliff-drop" borders and can develop at any age.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Linear forms of lichen planus, lichen planus pigmentosus, and fixed drug eruption </strong>–<strong> </strong>A gray-brown color due to pigment incontinence is often evident in these inflammatory conditions, which can develop at any age. Biopsy is helpful in confirming the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/5662.html" rel="external">"Lichen planus"</a> and  <a class="medical medical_review" href="/z/d/html/15760.html" rel="external">"Fixed drug eruption"</a> and  <a class="medical medical_review" href="/z/d/html/89268.html" rel="external">"Acquired hyperpigmentation disorders", section on 'Lichen planus pigmentosus'</a>.)</p><p></p><p class="headingAnchor" id="H855774370"><span class="h2">Hypopigmentation or depigmentation in a block-like pattern</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Segmental vitiligo</strong> – In children, vitiligo may present with completely depigmented lesions with sharply defined borders in a patchy segmental distribution  (<a class="graphic graphic_picture graphicRef72369" href="/z/d/graphic/72369.html" rel="external">picture 11</a>). The stark white color typically accentuated with Wood's lamp examination and presence of perifollicular repigmentation suggest the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/105109.html" rel="external">"Vitiligo: Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H3772175283"><span class="h2">Hyperpigmentation in a block-like pattern</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>McCune-Albright syndrome </strong>– This rare sporadic disorder is caused by a postzygotic activating mutation in <em>GNAS</em>, the gene encoding the alpha-subunit of the G protein that stimulates adenylate cyclase activity. The segmental hyperpigmentation of McCune-Albright syndrome may follow the lines of Blaschko in broad bands and tends to be darker than a typical café-au-lait macule (CALM), with sharply demarcated, irregular ("coast of Maine") borders  (<a class="graphic graphic_picture graphicRef96333" href="/z/d/graphic/96333.html" rel="external">picture 12</a>) [<a href="#rid38">38</a>]. Other manifestations include polyostotic fibrous dysplasia of the bone and endocrine activation (classically precocious puberty). (See  <a class="medical medical_review" href="/z/d/html/111807.html" rel="external">"Congenital and inherited hyperpigmentation disorders", section on 'McCune-Albright syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurofibromatosis type 1 and Legius syndrome </strong>– In neurofibromatosis type 1 (NF1) and NF1-like syndrome (Legius syndrome), a large block-like CALM is occasionally seen in association with multiple smaller CALMs in a widespread distribution. The CALMs of NF1 typically have regular borders, and sometimes large lesions have an underlying plexiform neurofibroma with a "bag of worms" consistency upon palpation. Other stigmata of NF1 (such as intertriginous freckling, Lisch nodules, and neurofibromas) may be evident, depending upon the age of the patient. In segmental NF1, multiple CALMs and often lentigines are found in a segmental distribution, with slightly darker background pigmentation in this area compared with the patient's unaffected skin. (See  <a class="medical medical_review" href="/z/d/html/111807.html" rel="external">"Congenital and inherited hyperpigmentation disorders", section on 'Neurofibromatosis type 1-like syndrome (Legius syndrome)'</a> and  <a class="medical medical_review" href="/z/d/html/111807.html" rel="external">"Congenital and inherited hyperpigmentation disorders", section on 'Neurofibromatosis type 1'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Large/giant café-au-lait macule </strong>– CALMs tend to be oval or round in shape without midline demarcation; their borders are sharply defined, without fading at the lateral margin [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Becker nevus</strong> – Becker nevus presents as a hyperpigmented patch that typically breaks up into smaller macules at its periphery and may have associated hypertrichosis  (<a class="graphic graphic_picture graphicRef68895" href="/z/d/graphic/68895.html" rel="external">picture 13</a>). It favors the upper lateral trunk and can either be congenital or appear around the time of puberty. Skin biopsy shows subtle features of a smooth muscle hamartoma. (See  <a class="medical medical_review" href="/z/d/html/5560.html" rel="external">"Benign pigmented skin lesions other than melanocytic nevi (moles)", section on 'Becker nevus'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Speckled lentiginous nevus (nevus spilus) </strong>– Macular and/or papular "speckles" representing lentigines and melanocytic nevi of various types (including Spitz nevi in some patients) progressively develop on a hyperpigmented background patch, which may be large and block-like  (<a class="graphic graphic_picture graphicRef94650" href="/z/d/graphic/94650.html" rel="external">picture 14</a>). (See  <a class="medical medical_review" href="/z/d/html/4847.html" rel="external">"Congenital melanocytic nevi", section on 'Speckled lentiginous nevus'</a>.)</p><p></p><p class="headingAnchor" id="H2094579721"><span class="h2">Chimerism</span><span class="headingEndMark"> — </span>An individual composed of two genetically distinct original cell lines (eg, by fertilization of one egg by two sperm or fusion of two zygotes) may display an admixture of lighter and darker skin pigmentation. This often has a checkerboard configuration with sharp midline demarcation, but patterns range from almost perfect rectangles to narrow bands to ill-defined, mottled patches [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H1783995129"><span class="h2">Pigmentary demarcation lines</span><span class="headingEndMark"> — </span>These bilateral, symmetric physiologic lines of demarcation between the ventral and relatively hyperpigmented dorsal surfaces are most evident in individuals with darkly pigmented skin and should not be confused with pigmentary mosaicism. (See  <a class="medical medical_review" href="/z/d/html/111807.html" rel="external">"Congenital and inherited hyperpigmentation disorders", section on 'Pigmentary demarcation lines'</a>.)</p><p>The five major forms on the trunk and extremities are:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type A (most common)</strong> – Vertical line on the anterolateral upper arm, sometimes extending to the chest  (<a class="graphic graphic_picture graphicRef95259" href="/z/d/graphic/95259.html" rel="external">picture 15</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type B </strong>– Curved line on the posteromedial thigh, sometimes extending to the ankle  (<a class="graphic graphic_picture graphicRef96050" href="/z/d/graphic/96050.html" rel="external">picture 16</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type C </strong>– Vertical or curved hypopigmented band on the mid chest resulting from two parallel pigmentary demarcation lines</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type D </strong>– Vertical line along the spine</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type E </strong>–<strong> </strong>Hypopigmented macules/patches on the chest from mid clavicle to areola</p><p></p><p class="headingAnchor" id="H703754747"><span class="h1">MANAGEMENT AND FOLLOW-UP</span><span class="headingEndMark"> — </span>Management of pigmentary mosaicism is directed at extracutaneous manifestations when present. The abnormal skin pigmentation does not typically respond well to treatments, although some fading of linear nevoid hyperpigmentation has been reported with the use of Q-switched lasers [<a href="#rid39">39</a>].</p><p>Long-term follow-up with the child's pediatrician is important to monitor growth and development over time. Any suspected extracutaneous abnormalities that arise should be properly investigated and managed by the appropriate specialist.</p><p class="headingAnchor" id="H983979712"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The prognosis for most individuals with pigmentary mosaicism without extracutaneous findings is excellent. Although the pigmentary alteration is usually persistent, fading of hyperpigmented lesions has been reported [<a href="#rid7">7,40</a>].</p><p>In patients with extracutaneous findings, the clinical course and prognosis vary, based upon the type and extent of the underlying abnormalities.</p><p class="headingAnchor" id="H2168505659"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Pigmentary mosaicism refers to patterned hypo- or hyperpigmentation that results from a clone of skin cells with altered ability to produce melanin. A wide variety of underlying mosaic cytogenetic abnormalities have been identified. (See <a class="local">'Introduction'</a> above and <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical</strong> <strong>patterns</strong> – The three major clinical patterns of pigmentary mosaicism are: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Linear nevoid hypo-/hyperpigmentation, with streaks and swirls following Blaschko lines  (<a class="graphic graphic_picture graphicRef110210 graphicRef110211" href="/z/d/graphic/110210.html" rel="external">picture 1A-B</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Segmental pigmentation disorder, showing segmental or "checkerboard" distribution, often with midline demarcation on the anterior trunk  (<a class="graphic graphic_picture graphicRef110214" href="/z/d/graphic/110214.html" rel="external">picture 3</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Phylloid pattern, usually phylloid hypomelanosis due to mosaic trisomy 13q  (<a class="graphic graphic_picture graphicRef110216" href="/z/d/graphic/110216.html" rel="external">picture 4</a>) (see <a class="local">'Clinical manifestations'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extracutaneous manifestations</strong> – A small minority (≤15 percent) of individuals with linear nevoid hypo-/hyperpigmentation have associated extracutaneous findings, most often neurodevelopmental abnormalities that become apparent during infancy. The term "hypomelanosis of Ito" should be reserved for this subgroup of patients. (See <a class="local">'Extracutaneous manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of pigmentary mosaicism is usually clinical, based on the pattern and distribution of hypo- and hyperpigmentation. Genetic analysis should be considered in children with extracutaneous abnormalities. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – The management of pigmentary mosaicism involves a thorough history and physical examination to assess for extracutaneous involvement, with further evaluation directed by any abnormal findings. The abnormal skin pigmentation does not typically respond well to treatment. Long-term follow-up with the child's pediatrician is important to monitor growth and development over time. (See <a class="local">'Management and follow-up'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Schaffer JV. Pigmentary mosaicism. Clin Dermatol 2022; 40:322.</a></li><li><a class="nounderline abstract_t">Cohen J 3rd, Shahrokh K, Cohen B. Analysis of 36 cases of Blaschkoid dyspigmentation: reading between the lines of Blaschko. Pediatr Dermatol 2014; 31:471.</a></li><li><a class="nounderline abstract_t">Nehal KS, PeBenito R, Orlow SJ. Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch Dermatol 1996; 132:1167.</a></li><li><a class="nounderline abstract_t">Ruiz-Maldonado R, Toussaint S, Tamayo L, et al. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol 1992; 9:1.</a></li><li><a class="nounderline abstract_t">Taibjee SM, Bennett DC, Moss C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. Br J Dermatol 2004; 151:269.</a></li><li><a class="nounderline abstract_t">Di Lernia V. Segmental nevus depigmentosus: analysis of 20 patients. Pediatr Dermatol 1999; 16:349.</a></li><li><a class="nounderline abstract_t">Metzker A, Morag C, Weitz R. Segmental pigmentation disorder. Acta Derm Venereol 1983; 63:167.</a></li><li><a class="nounderline abstract_t">Hogeling M, Frieden IJ. Segmental pigmentation disorder. Br J Dermatol 2010; 162:1337.</a></li><li><a class="nounderline abstract_t">Torchia D, Happle R. Segmental hypomelanosis and hypermelanosis arranged in a checkerboard pattern are distinct naevi: flag-like hypomelanotic naevus and flag-like hypermelanotic naevus. J Eur Acad Dermatol Venereol 2015; 29:2088.</a></li><li><a class="nounderline abstract_t">Pascual-Castroviejo I, López-Rodriguez L, de la Cruz Medina M, et al. Hypomelanosis of Ito. Neurological complications in 34 cases. Can J Neurol Sci 1988; 15:124.</a></li><li><a class="nounderline abstract_t">Happle R. Monoallelic expression on autosomes may explain an unusual heritable form of pigmentary mosaicism: a historical case revisited. Clin Exp Dermatol 2009; 34:834.</a></li><li><a class="nounderline abstract_t">Horn D, Happle R, Neitzel H, Kunze J. Pigmentary mosaicism of the hyperpigmented type in two half-brothers. Am J Med Genet 2002; 112:65.</a></li><li><a class="nounderline abstract_t">Montagna P, Procaccianti G, Galli G, et al. Familial hypomelanosis of Ito. Eur Neurol 1991; 31:345.</a></li><li><a class="nounderline abstract_t">Mirzaa GM, Campbell CD, Solovieff N, et al. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism. JAMA Neurol 2016; 73:836.</a></li><li><a class="nounderline abstract_t">González-Enseñat MA, Vicente A, Poo P, et al. Phylloid hypomelanosis and mosaic partial trisomy 13: two cases that provide further evidence of a distinct clinicogenetic entity. Arch Dermatol 2009; 145:576.</a></li><li><a class="nounderline abstract_t">Happle R, Franco-Guío MF, Santacoloma-Osorio G. Phylloid hypermelanosis: a cutaneous marker of several different disorders? Pediatr Dermatol 2014; 31:504.</a></li><li><a class="nounderline abstract_t">Thapa R, Dhar S, Malakar R, Chakrabartty S. Hypomelanosis of ito-whorled hyperpigmentation combination: a mirror image presentation. Pediatr Dermatol 2007; 24:572.</a></li><li><a class="nounderline abstract_t">Restano L, Barbareschi M, Cambiaghi S, et al. Heterochromia of the scalp hair: a result of pigmentary mosaicism? J Am Acad Dermatol 2001; 45:136.</a></li><li><a class="nounderline abstract_t">Khurana A, Singal A, Pandhi D. Hypomelanosis of Ito and multiple naevoid hypertrichosis: rare cutaneous mosaicism. Australas J Dermatol 2014; 55:e29.</a></li><li><a class="nounderline abstract_t">Shimizu K, Makino T, Ueda C, et al. Detection of hypohidrosis in Japanese patients with pigmentary mosaicism. Eur J Dermatol 2013; 23:913.</a></li><li><a class="nounderline abstract_t">Treat J. Patterned pigmentation in children. Pediatr Clin North Am 2010; 57:1121.</a></li><li><a class="nounderline abstract_t">Pavone P, Praticò AD, Ruggieri M, Falsaperla R. Hypomelanosis of Ito: a round on the frequency and type of epileptic complications. Neurol Sci 2015; 36:1173.</a></li><li><a class="nounderline abstract_t">Pavone V, Signorelli SS, Praticò AD, et al. Total Hemi-overgrowth in Pigmentary Mosaicism of the (Hypomelanosis of) Ito Type: Eight Case Reports. Medicine (Baltimore) 2016; 95:e2705.</a></li><li><a class="nounderline abstract_t">Arghir A, Popescu R, Resmerita I, et al. Pallister-Killian Syndrome versus Trisomy 12p-A Clinical Study of 5 New Cases and a Literature Review. Genes (Basel) 2021; 12.</a></li><li><a class="nounderline abstract_t">Myers JN Jr, Davis L, Sheehan D, Kulharya AS. Mosaic tetrasomy 13q and phylloid hypomelanosis: a case report and review of the literature. Pediatr Dermatol 2015; 32:263.</a></li><li><a class="nounderline abstract_t">Oiso N, Tsuruta D, Imanishi H, et al. Phylloid hypermelanosis and melanocytic nevi with aggregated and disfigured melanosomes: causal relationship between phylloid pigment distribution and chromosome 13 abnormalities. Dermatology 2010; 220:169.</a></li><li><a class="nounderline abstract_t">Happle R. Phylloid hypermelanosis: an unusual form of pigmentary mosaicism. Dermatology 2010; 220:183.</a></li><li><a class="nounderline abstract_t">Küster W, König A. Hypomelanosis of Ito: no entity, but a cutaneous sign of mosaicism. Am J Med Genet 1999; 85:346.</a></li><li><a class="nounderline abstract_t">Lee HS, Chun YS, Hann SK. Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients. J Am Acad Dermatol 1999; 40:21.</a></li><li><a class="nounderline abstract_t">Mehta V, Vasanth V, Balachandran C, Mathew M. Linear and whorled nevoid hypermelanosis. Int J Dermatol 2011; 50:491.</a></li><li><a class="nounderline abstract_t">Ertam I, Turk BG, Urkmez A, et al. Linear and whorled nevoid hypermelanosis: dermatoscopic features. J Am Acad Dermatol 2009; 60:328.</a></li><li><a class="nounderline abstract_t">Di Lernia V. Linear and whorled hypermelanosis. Pediatr Dermatol 2007; 24:205.</a></li><li><a class="nounderline abstract_t">Sybert VP. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol 1994; 103:141S.</a></li><li><a class="nounderline abstract_t">Taibjee SM, Hall D, Balderson D, et al. Keratinocyte cytogenetics in 10 patients with pigmentary mosaicism: identification of one case of trisomy 20 mosaicism confined to keratinocytes. Clin Exp Dermatol 2009; 34:823.</a></li><li><a class="nounderline abstract_t">Tümer Z, Møller LB. Menkes disease. Eur J Hum Genet 2010; 18:511.</a></li><li><a class="nounderline abstract_t">Fete M, Hermann J, Behrens J, Huttner KM. X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry. Am J Med Genet A 2014; 164A:2437.</a></li><li><a class="nounderline abstract_t">de Golian E, Echols K, Pearl H, Davis L. Linear atrophoderma of Moulin: a distinct entity? Pediatr Dermatol 2014; 31:373.</a></li><li><a class="nounderline abstract_t">Rieger E, Kofler R, Borkenstein M, et al. Melanotic macules following Blaschko's lines in McCune-Albright syndrome. Br J Dermatol 1994; 130:215.</a></li><li><a class="nounderline abstract_t">Catherine S, Lacour JP, Passeron T. Treatment of linear and whorled hypermelanosis with Q-switched laser. Dermatol Surg 2014; 40:1044.</a></li><li><a class="nounderline abstract_t">Lombillo VA, Sybert VP. Mosaicism in cutaneous pigmentation. Curr Opin Pediatr 2005; 17:494.</a></li></ol></div><div id="topicVersionRevision">Topic 97404 Version 8.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35288277" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Pigmentary mosaicism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25039703" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Analysis of 36 cases of Blaschkoid dyspigmentation: reading between the lines of Blaschko.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8859026" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1574469" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Hypomelanosis of Ito: diagnostic criteria and report of 41 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15327534" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10571831" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Segmental nevus depigmentosus: analysis of 20 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6189338" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Segmental pigmentation disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20163411" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Segmental pigmentation disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25752916" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Segmental hypomelanosis and hypermelanosis arranged in a checkerboard pattern are distinct naevi: flag-like hypomelanotic naevus and flag-like hypermelanotic naevus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3383022" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hypomelanosis of Ito. Neurological complications in 34 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19747340" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Monoallelic expression on autosomes may explain an unusual heritable form of pigmentary mosaicism: a historical case revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12239723" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pigmentary mosaicism of the hyperpigmented type in two half-brothers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1756756" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Familial hypomelanosis of Ito.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27159400" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19451503" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Phylloid hypomelanosis and mosaic partial trisomy 13: two cases that provide further evidence of a distinct clinicogenetic entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23278628" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Phylloid hypermelanosis: a cutaneous marker of several different disorders?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17958820" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Hypomelanosis of ito-whorled hyperpigmentation combination: a mirror image presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11423851" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Heterochromia of the scalp hair: a result of pigmentary mosaicism?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23425222" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hypomelanosis of Ito and multiple naevoid hypertrichosis: rare cutaneous mosaicism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24184501" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Detection of hypohidrosis in Japanese patients with pigmentary mosaicism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20888462" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Patterned pigmentation in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25586695" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Hypomelanosis of Ito: a round on the frequency and type of epileptic complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26962770" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Total Hemi-overgrowth in Pigmentary Mosaicism of the (Hypomelanosis of) Ito Type: Eight Case Reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34073526" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pallister-Killian Syndrome versus Trisomy 12p-A Clinical Study of 5 New Cases and a Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24920397" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Mosaic tetrasomy 13q and phylloid hypomelanosis: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20110628" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Phylloid hypermelanosis and melanocytic nevi with aggregated and disfigured melanosomes: causal relationship between phylloid pigment distribution and chromosome 13 abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20110629" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Phylloid hypermelanosis: an unusual form of pigmentary mosaicism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10398257" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Hypomelanosis of Ito: no entity, but a cutaneous sign of mosaicism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9922008" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21413967" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Linear and whorled nevoid hypermelanosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19150278" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Linear and whorled nevoid hypermelanosis: dermatoscopic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17542865" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Linear and whorled hypermelanosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7963677" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Hypomelanosis of Ito: a description, not a diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19438553" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Keratinocyte cytogenetics in 10 patients with pigmentary mosaicism: identification of one case of trisomy 20 mosaicism confined to keratinocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19888294" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Menkes disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24664614" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : X-linked hypohidrotic ectodermal dysplasia (XLHED): clinical and diagnostic insights from an international patient registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23046463" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Linear atrophoderma of Moulin: a distinct entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8123575" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Melanotic macules following Blaschko's lines in McCune-Albright syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25099293" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Treatment of linear and whorled hypermelanosis with Q-switched laser.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16012262" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Mosaicism in cutaneous pigmentation.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
